SCiAN was founded in 1986 with a focus on clinical research consulting and has since evolved into a specialized Contract Research Organization supporting the full spectrum of clinical data and biometrics services.

Over the past four decades, we have supported more than 700 clinical studies across Phase I–IV programs, including IND-enabling studies, pivotal trials, and regulatory submissions. Our experience spans a wide range of therapeutic areas, including oncology, CNS, infectious diseases, autoimmune disorders, and metabolic diseases.

We have grown alongside our clients, supporting emerging biotechnology companies as they progress from early development through clinical milestones and, in many cases, through acquisition, licensing, or strategic partnership with global pharmaceutical organizations.

Across these transitions, SCiAN has remained a trusted continuity partner—maintaining institutional knowledge, ensuring data integrity, and supporting ongoing clinical development under evolving sponsorship structures.

Today, SCiAN continues to build on this legacy by delivering high-quality biometrics and clinical data solutions that support efficient, compliant, and successful drug development.